Megan joined CBSSM in 2014 and has worked on multiple grant funded research projects related to health communication, patient-provider decision making, and health interventions driven by behavioral economics. She currently works with Dr. Brian Zikmund-Fisher on a National Science Foundation grant testing infectious disease communication strategies.
Page not found
This two-day conference took place on the UM campus and is presented by the University of Michigan Medical School. It was also supported by the Office of the Vice President for Research; the Center for Ethics and Public Life; Rackham Distinguished Faculty Grant; Greenwall Foundation; and Institute for Social Policy and Understanding. Click here for conference videos, course packets, and reference materials.
Dr. Scherer was a VA and CBSSM Postdoctoral Research Fellow, 2010-2012. She received her PhD in social psychology in 2010 from Washington University in St. Louis.
Dr. Scherer is currently an Assistant Professor of Psychological Sciences at the University of Missouri.
Vaccine refusal has an impact on public health; however, research has shown that it is very difficult to change attitudes towards vaccines. People are often hesitant about vaccines because they don’t trust that potential harms are documented and reported. The question is: how can we increase trust and vaccine utilization?
This special interest group is led by Dr. Scott Roberts who is an Associate Professor in the Department of Health Behavior and Health Education at the School of Public Health as well as the Director and Co-Director of the Public Health Genetics Certificate Program and the Dual Degree Program in Public Health and Genetic Counseling, respectively. Research within this area examines the ethical, social and behavioral implications of advances in genomics. CBSSM serves as a crucial locus for facilitating collaborations across disciplines and units. In fact, several groups across campus have invited us to collaborate on the study of bioethical issues related to burgeoning genomics-related research; these partners include investigators at U-M’s Comprehensive Cancer Center, the Michigan Center for Translational Pathology, and the Division of Pediatric Genetics.
Topics of interest include the following:
- The psychological and behavioral impact of genetic testing (Scott Roberts; Brian Zikmund-Fisher)
- Communication of genetic risk information (Michele Gornick; Scott Roberts; Beth Tarini; Brian Zikmund-Fisher)
- Direct-to-consumer genetic testing (Scott Roberts)
- Healthcare provider education in genomics (Scott Roberts)
- Informed consent in genomic research (Michele Gornick)
- Expert decision-making in genomic medicine (Raymond De Vries)
- Public understanding of genomics (Michele Gornick; Scott Roberts)
- Ethical and policy implications of genomic discoveries (Michele Gornick; Raymond De Vries)
Dr. Aisha Langford was a VA and CBSSM Postdoctoral Research Fellow, 2013-2015. She received her PhD from the department of Health Behavior and Health Education at the University of Michigan School of Public Health in Ann Arbor. From 2007 -2013, she directed the University of Michigan Comprehensive Cancer Center’s Community Outreach Program. Her research interests include chronic disease prevention and control, health communications, medical decision making, and clinical trial participation. Aisha is from the San Francisco Bay Area and earned her BA from the University of Virginia.
Michele Gornick, PhD
VA HSRD Fellow & CBSSM Research Investigator
Title: The public’s preferences for the return of secondary findings identified through genome sequencing: Information and deliberation make a difference
Summary: Genomic sequencing is becoming a part of clinical practice. Existing studies are limited and conclude that people would like unrestricted access to all of their genetic information. However, we do not know the extent to which respondents in these studies took into account the complex scientific and ethical issues that attend genome sequencing. In order to address this gap, we organized a deliberative democracy (DD) session to educate members of the public on genome sequencing, to engage them in dialogue about the benefits and risks of the clinical implementation of this technology, and to elicit their informed perspectives about policies governing the return of secondary findings.
Jodyn Platt, MPH, PhD
Department of Learning Health Sciences
Terms and Conditions for Trust in Learning Health Systems
The next generation of health information technology, organized as “learning health systems,” promises efficient, engineered solutions to the well-known and enduring maladies of the existing U.S. health infrastructure: escalating costs, poor health outcomes, ineffective use of technology, sluggish research pipelines, dangerous medical error rates, and failure to implement known clinical best practices. Learning health systems would capitalize on "big data" enterprises to accelerate the production and application of knowledge in health care. However, the sharing of health information required, both within and across institutions, greatly exceeds the public’s understanding. These initiatives are riding a precarious edge as the gap between public expectations and the realities of institutional data sharing widens at an unprecedented rate. This presentation considers the causes and consequences of trust and mistrust of health information systems, their data sharing practices, and their policy implications.